Hypozincemia in Chronic Hepatitis C Is Improved with Viral Clearance by Direct-acting Antiviral Agents

OBJECTIVE: Hypozincemia is a decrease in the serum zinc level of patients with hepatitis C and often requires zinc supplementation to improve the hepatic function. Our previous study showed the efficacy of direct-acting antiviral agent (DAA) treatment on serum zinc levels in patients with hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirahashi, Ryosaku, Suda, Toshikuni, Tamano, Masaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990624/
https://www.ncbi.nlm.nih.gov/pubmed/33642558
http://dx.doi.org/10.2169/internalmedicine.5738-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990624/
https://www.ncbi.nlm.nih.gov/pubmed/33642558
http://dx.doi.org/10.2169/internalmedicine.5738-20

Ejemplares similares